EventsThe 1st International Online Conference on Biology
Published
This submission belongs to the session S4. Infection Biology of the event The 1st International Online Conference on Biology
Published date
05 Feb, 2026
Academic Editor
author-avatarOswaldo Palenzuela
Citation
Ahmed Olatunde, Meshach Zachariah, Mandi Istifanus Nuhu, Titilayo O. Johnson, Structure-based in silico identification of antimalarial lead compounds from Dioclea reflexa targeting essential Plasmodium falciparum enzymes, in Proceedings of The 1st International Online Conference on Biology, 10 February–12 February 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Structure-based in silico identification of antimalarial lead compounds from Dioclea reflexa targeting essential Plasmodium falciparum enzymes

Meshach Zachariah 2
1. Department of Medical Biochemistry, Abubakar Tafawa Balewa University, Bauchi 740272, Nigeria, Nigeria
2. Department of Biochemistry, Abubakar Tafawa Balewa University, Bauchi 740272, Nigeria, Nigeria
3. Department of Biochemistry, University of Jos, Jos, Nigeria, Nigeria
Abstract

Malaria remains a global health crisis, primarily driven by drug-resistant Plasmodium falciparum strains, necessitating the urgent discovery of novel and safe antimalarial agents. The aim of this study was to identify potent inhibitors against four essential P. falciparum enzymes: PfCullin-2, PfNADP-IDH, PfPKG, and PfAMA1. This study employed a structure-based in silico approach, combining molecular docking, drug-likeness and ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) analyses, to screen phytochemicals from Dioclea reflexa. Molecular docking results identified three potent lead compounds with high binding affinities (ΔG) often surpassing or equaling standard antimalarial drugs. The most potent hit was the phytosterol β-Sitosterol which showed a maximum affinity of −10.7 kcal/mol against PfCullin-2, exceeding the affinity of the control drug Atovaquone (−10.4 kcal/mol). Moreover, Lupeol (triterpenoid) was a dual inhibitor, demonstrating significantly superior binding to PfNADP-IDH (−9.6 kcal/mol) and PfAMA1 (−8.4 kcal/mol) compared to Primaquine (−5.7 and −6.6 kcal/mol, respectively). The flavonoid 7,4'-Dihydroxyflavone exhibited a docking score of −8.9 kcal/mol against PfPKG, comparable to the reference drug Artemisinin (−9.2 kcal/mol). Pharmacokinetic evaluation revealed a trade-off between potency and drug-likeness. While β-Sitosterol and Lupeol are the most potent binders against the malaria target receptors, their high lipophilicity resulted in one Lipinski violation and predicted poor aqueous solubility. In contrast, 7,4'-Dihydroxyflavone showed zero Lipinski violations and good solubility, establishing it as the most drug-like candidate. Toxicity screening predicted all three compounds to be inactive for major risks including hepatotoxicity, mutagenicity, and carcinogenicity. However, β-Sitosterol and Lupeol were flagged for neurotoxicity, while 7,4'-Dihydroxyflavone was flagged for nephrotoxicity.

Keywords
Malaria
Plasmodium falciparum
molecular docking
β-sitosterol
lupeol
7,4'-dihydroxyflavone
Morphological characterization of the genetic resources of Moroccan white mulberry (Morus alba L.)
Pathology and Aetiology of Pneumonia in Nigerian Sheep: Evidence of Viral–Bacterial Co-infections and Breed Susceptibility